Hochman David P
See Remarks
Hochman David P has filed 12 SEC Form 4 filings (17 transaction rows) across 1 company, with disclosures dating back to 2025. 11 of those filings fall inside the rolling window. Most recent filing: Sep 11, 2026.
On the most recent filing, Hochman David P is listed as See Remarks at Orchestra BioMed Holdings, Inc. Inside the rolling window, Hochman David P reported 5 open-market purchases totaling $149K in OBIO and no open-market sales. The largest disclosed transaction in the window is a purchase of 10,000 OBIO shares on Sep 3, 2026, worth $48K.
Companies traded
Other insiders at OBIO
Insider Buying
$149K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Hochman David P made?
Hochman David P has filed 12 SEC Form 4 filings (17 transaction rows) across 1 company since 2025.
Which companies does Hochman David P trade?
Hochman David P has filed SEC Form 4 disclosures for 1 company, including OBIO.
When was Hochman David P's most recent SEC Form 4 filing?
Hochman David P's most recent SEC Form 4 filing on Tracefour is dated Sep 11, 2026.
What is Hochman David P's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Hochman David P is listed as See Remarks.
What is Hochman David P's total buy and sell value in the current window?
Inside the rolling retention window, Hochman David P bought $149K and sold $0 based on SEC Form 4 filings.
What was Hochman David P's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 10,000 OBIO shares on 2026-09-03, worth $48K, per SEC Form 4 filings.